Data / Form D filings / TISSUE GENESIS INC.
TISSUE GENESIS INC.: Form D filings
TISSUE GENESIS INC., a biotechnology company in Honolulu, HI, filed 7 Form D notices with the SEC between 2010 and 2014. The latest, on September 3, 2014, reports $500,000 sold of a $6 million offering to 1 investor.
Find out what TISSUE GENESIS INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 810 RICHARDS STREET, SUITE 1000, Honolulu, HI, 96813
- Phone
- (808) 772-5525
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Hawaii
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1210070
The full lists. Form D filings in Hawaii: 59 rows, $5, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 3, 2014 | New notice | $6,000,000 | $500,000 | $5,500,000 | 1 | Aug 22, 2014 | sec.gov |
| Jan 4, 2012 | New notice | $15,300,000 | $7,737,709 | $7,562,291 | 53 | Dec 30, 2011 | sec.gov |
| Jul 11, 2011 | New notice | $15,300,000 | $5,634,005 | $9,665,995 | 51 | Jun 30, 2010 | sec.gov |
| Jan 5, 2011 | New notice | $15,300,000 | $4,461,600 | $10,838,400 | 40 | Jun 30, 2010 | sec.gov |
| Jul 2, 2010 | New notice | $15,300,000 | $1,330,400 | $13,969,600 | 9 | Jun 30, 2010 | sec.gov |
| Apr 22, 2010 | New notice | $9,000,000 | $1,120,000 | $7,880,000 | 3 | Mar 31, 2010 | sec.gov |
| Apr 22, 2010 | New notice | $9,000,000 | $120,000 | $8,880,000 | 2 | Dec 30, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Lawrence C. Rodriguez | Director | |
| Paul C. Kosnik | Executive Officer | |
| Michael C. Ruley | Director | |
| Anton C. Krucky | Executive Officer, Director | |
| Robert C. Hiam | Director | |
| Timothy C. Sarhatt | Director | |
| Thomas C. Cannon | Executive Officer, Director |
Every Form D from the week of Sep 1, 2014 · All recent filings in Hawaii · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what TISSUE GENESIS INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.